已收盤 02-06 16:00:00 美东时间
+0.500
+4.97%
AngioDynamics Secures FDA IDE Approval and Expanded 510(k) Clearance for AlphaVac System AngioDynamics Inc. announced that it received FDA approval in November 2025 for its Investigational Device Exemption (IDE) application for the APEX-Return pivotal study. This study will evaluate the safety and e
02-03 21:02
FDA genehmigt IDE-Antrag von AngioDynamics für APEX-Return-Studie AngioDynamics Inc. hat im November 2025 die Genehmigung der US-amerikanischen Food and Drug Administration (FDA) für den IDE-Antrag zur APEX-Return-Studie erhalten. In der Studie wird die Sicherheit und Wirksamkeit des AlphaReturn Blo
02-03 21:02
Angiodynamics, Inc. (($ANGO)) has held its Q2 earnings call. Read on for the ma...
01-07 08:02
AngioDynamics ( ($ANGO) ) has provided an update. On January 6, 2026, AngioDyna...
01-06 20:49
Today, several major companies are expected to report earnings: AAR (AIR), Angi...
01-06 20:05
AngioDynamics press release (ANGO): Q2 Non-GAAP EPS of $0.00 beats by $0.10. Revenue of $79.43M (+8.8% Y/Y) beats by $3M. Jim Clemmer to retire during fiscal year 2027 as President and CEO upon appoin...
01-06 19:30
Companies Reporting Before The Bell • AngioDynamics (NASDAQ:ANGO) is estimated ...
01-06 19:11
U.S. stocks rise on Venezuela raids, Dow hits record high. CNN Money Fear and Greed Index improves but remains in Neutral zone at 46.8.
01-06 15:48
AngioDynamics (ANGO) is scheduled to announce FQ2 earnings results on Tuesday, January 6th, before market open. The consensus EPS Estimate is -$0.10 and the consensus Revenue Estimate is $76.43M. Over...
01-06 00:25
AngioDynamics (ANGO) exceeds expectations, raises guidance for fiscal 2026 with positive cash flow expected.
2025-10-04 00:47